Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Family-oriented setup guidance to allocate every dollar and align spending with collective priorities.
19,524 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...
When insiders trade, investors pay attention. This article breaks down what seacoast banking corp. sells signals, how...
Investors woke up to a sharp move in Life360 after a strong Q4 report, but guiding headwinds sparked a sell-off. This...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Datarails rolls out FinanceOS, an AI-native platform pitched as a financial operating system designed to disrupt its ...
SpaceX’s planned IPO could force immediate inclusion in Nasdaq-100 ETFs, igniting volatility for QQQ and other tracke...
Geopolitics rarely stays in headlines for long, but the impact on crypto can be swift and surprising. This guide help...
Bitcoin nears new highs as Zcash and MemeCore lead a double-digit rally among smaller tokens, while Ethereum and XRP ...
In this analysis, we unpack what Andy Jassy's recent remarks mean for Amazon stock and AWS growth. Learn actionable s...
The Invesco S&P 500 Momentum ETF (SPMO) is again outperforming SPY on a trailing basis while showing resilience durin...
Kalshi unveils a $1 billion March Madness bracket contest, modeled after Warren Buffett’s famous wager. The scheme te...